BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29476905)

  • 21. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
    Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
    Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy.
    Feidantsis K; Mellidis K; Galatou E; Sinakos Z; Lazou A
    Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):952-961. PubMed ID: 30017436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy.
    Tan X; Hu L; Shu Z; Chen L; Li X; Du M; Sun D; Mao X; Deng S; Huang K; Zhang F
    Diabetes; 2019 Nov; 68(11):2063-2073. PubMed ID: 31439648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
    Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice.
    Guo Z; Tuo H; Tang N; Liu FY; Ma SQ; An P; Yang D; Wang MY; Fan D; Yang Z; Tang QZ
    Int J Biol Sci; 2022; 18(2):826-840. PubMed ID: 35002528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helix B surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy.
    Lin C; Zhang M; Zhang Y; Yang K; Hu J; Si R; Zhang G; Gao B; Li X; Xu C; Li C; Hao Q; Guo W
    Biochem Biophys Res Commun; 2017 Jan; 482(4):665-671. PubMed ID: 27865838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation.
    Zhang M; Wang S; Cheng Z; Xiong Z; Lv J; Yang Z; Li T; Jiang S; Gu J; Sun D; Fan Y
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1280-1287. PubMed ID: 28965951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
    Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy.
    Zhang Y; Zou R; Abudureyimu M; Liu Q; Ma J; Xu H; Yu W; Yang J; Jia J; Qian S; Wang H; Yang Y; Wang X; Fan X; Ren J
    J Mol Cell Biol; 2024 Apr; 15(9):. PubMed ID: 37771085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy.
    Suzuki H; Kayama Y; Sakamoto M; Iuchi H; Shimizu I; Yoshino T; Katoh D; Nagoshi T; Tojo K; Minamino T; Yoshimura M; Utsunomiya K
    Diabetes; 2015 Feb; 64(2):618-30. PubMed ID: 25187369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway.
    Yin L; Fang Y; Song T; Lv D; Wang Z; Zhu L; Zhao Z; Yin X
    J Cell Mol Med; 2019 Apr; 23(4):2558-2567. PubMed ID: 30701683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice.
    Wu B; Lin J; Luo J; Han D; Fan M; Guo T; Tao L; Yuan M; Yi F
    Biomed Res Int; 2017; 2017():3764370. PubMed ID: 28421194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
    Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
    Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Mikami A; Ogino A; Watanabe T; Morishita K; Okada H; Kawasaki M; Seishima M; Minatoguchi S
    Autophagy; 2015; 11(7):1146-60. PubMed ID: 26042865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.